Pure Global
NCT06124521

Community Based Treatment for (ComBaT) Glaucoma

Increasing Eye Care Utilization in Black Americans At High Risk For Glaucoma Using A Community-Engaged and Faith-Based Intervention
University of Michigan·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
ComBaT Glaucoma
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Michigan
Location
Ann Arbor, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Nov 01, 2026
Enrollment
60 participants
Primary outcome

Eye care utilization

Summary

The purpose of this research is to evaluate if intervention and education can change the
 behavior of someone's willingness to see an eye care provider to prevent blindness and
 glaucoma. The researchers are investigating if adding additional resources improves
 participant access to care.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06124521
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06124521 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.